The Latest Breaking News from melanoma

Campaigners welcome Nice approval for use of Kimmtrak (tebentafusp) to treat patients with uveal melanoma

New drug avilable on the NHS could boost eye cancer patients’ survival time by months

Richard Scolyer was one of the world’s leading melanoma researchers when he was struck with a brain tumour. Facing likely death, his team made him a guinea pig for his own medicine

Lions DE Josh Paschal's triumph over melanoma is worth celebrating as he sits out Week 8

With the arrival of the warm season, we all find ourselves more exposed to the sun's rays, some for outdoor activities, some for the desire for tanned skin: it is useless to deny that many of us like the color of our skin kissed by the sun, perhaps ...

Charles met leading skin cancer experts as he visited the Melanoma Institute Australia in Sydney.

Sculpture often divides opinion but it’s rare for a work to carry the claim it may save lives

Data from a landmark international trial show half of patients with metastatic melanoma treated with a immune checkpoint people live cancer-free for 10 years or more. Read further on Dynamite News:

Merck's Keytruda scored two important victories in women's cancer, according to presentations Sunday at the ESMO meeting.